Arife Ulaş
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Diagnosis and Treatment
- Bone health and treatments
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Geriatrics and Gerontology top 10%
Papers in
-
- Renal cell carcinoma treatment 4
- Lung Cancer Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 4
- Oncology 17
- Cancer Diagnosis and Treatment 5
- HER2/EGFR in Cancer Research 3
- Inflammatory Biomarkers in Disease Prognosis 3
- Bone health and treatments 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Berna Öksüzoğlu (11 shared papers)Kamile Sılay (17 shared papers)Nilüfer Avcı (9 shared papers)Necati Alkış (9 shared papers)Fatma Paksoy Türköz (5 shared papers)Erdem Çubukçu (6 shared papers)Ahmet Bılıcı (6 shared papers)Saadettin Kılıçkap (1 shared paper)
In The Last Decade
Arife Ulaş
45 papers receiving 518 citations
Peers
Comparison fields: 5 of 67
- Oncology 231
- Geriatrics and Gerontology 20
- Pulmonary and Respiratory Medicine 143
- Cancer Research 52
- Emergency Medical Services 18
Countries citing papers authored by Arife Ulaş
This map shows the geographic impact of Arife Ulaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arife Ulaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arife Ulaş more than expected).
Fields of papers citing papers by Arife Ulaş
This network shows the impact of papers produced by Arife Ulaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arife Ulaş. The network helps show where Arife Ulaş may publish in the future.
Co-authors
The 25 scholars most cited alongside Arife Ulaş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 64 | |
| 2 | 2015 | 41 | |
| 3 | Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? | 2015 | 41 |
| 4 | 2014 | 40 | |
| 5 | 2015 | 37 | |
| 6 | 2013 | 28 | |
| 7 | 2012 | 23 | |
| 8 | 2010 | 20 | |
| 9 | 2012 | 19 | |
| 10 | 2015 | 17 | |
| 11 | 2012 | 16 | |
| 12 | Occult urinary incontinence in elderly women and its association with geriatric condition. | 2016 | 15 |
| 13 | Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. | 2015 | 15 |
| 14 | 2013 | 11 | |
| 15 | 2013 | 11 | |
| 16 | 2014 | 10 | |
| 17 | 2015 | 10 | |
| 18 | 2013 | 9 | |
| 19 | 2012 | 9 | |
| 20 | 2016 | 8 |
About Arife Ulaş
Arife Ulaş is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Surgery and Cardiology and Cardiovascular Medicine, having authored 48 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (5 papers), Renal cell carcinoma treatment (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Bone health and treatments (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (231 citations), Geriatrics and Gerontology (20 citations), Pulmonary and Respiratory Medicine (143 citations), Cancer Research (52 citations) and Emergency Medical Services (18 citations). Arife Ulaş has collaborated with scholars based in Türkiye, Kuwait and Norway. Frequent co-authors include Berna Öksüzoğlu, Kamile Sılay, Nilüfer Avcı, Necati Alkış, Fatma Paksoy Türköz, Erdem Çubukçu, Ahmet Bılıcı, Saadettin Kılıçkap, Şuayib Yalçın and Ayşe Durnalı. Their work appears in journals such as Medical Oncology, Tumor Biology, Annals of Oncology, Journal of Clinical Oncology and Asian Pacific Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.